EQRx racks up $200 mln Series A
EQRx, a Cambridge, Massachusetts-based drug company, has raised $200 million in Series A funding.
EQRx, a Cambridge, Massachusetts-based drug company, has raised $200 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination